These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21107130)

  • 1. Ptosis in Pompe disease: common genetic background in infantile and adult series.
    Ravaglia S; Bini P; Garaghani KS; Danesino C
    J Neuroophthalmol; 2010 Dec; 30(4):389-90. PubMed ID: 21107130
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease.
    Yanovitch TL; Casey R; Banugaria SG; Kishnani PS
    J Neuroophthalmol; 2010 Jun; 30(2):165-6. PubMed ID: 20404746
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-frequency enzyme replacement therapy in late-onset Pompe disease.
    Lin DS; Chiang MF; Ho CS; Hsiao CD; Lin CY; Wang NL; Chuang CK; Huang YW; Chang PC; Liu HL
    Muscle Nerve; 2013 Apr; 47(4):612-3. PubMed ID: 23322609
    [No Abstract]   [Full Text] [Related]  

  • 4. When should we start enzyme replacement therapy for infantile Pompe disease with severe cardiomyopathy?
    Bonilla-Palomas JL; Gámez-López AL; Tejero-Hernández MA; Tejero-Mateo I; López-López J
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):100-2. PubMed ID: 21715078
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term enzyme-replacement therapy (ERT) with alglucosidase alfa: Evolution of two siblings with juvenile late-onset Pompe disease.
    Rafael Bretón Martínez J; Martínez AC
    J Neurol Sci; 2015 Nov; 358(1-2):459-60. PubMed ID: 26279333
    [No Abstract]   [Full Text] [Related]  

  • 6. Infantile Pompe disease: clinical and genetic characteristics with an experience of enzyme replacement therapy.
    Cho A; Kim SJ; Lim BC; Hwang H; Park JD; Kim GB; Jin DK; Lee J; Ki CS; Kim KJ; Hwang YS; Chae JH
    J Child Neurol; 2012 Mar; 27(3):319-24. PubMed ID: 21940687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient therapy of Pompe disease by an acid α-glucosidase conjugate.
    Park K
    J Control Release; 2018 Jan; 269():441-442. PubMed ID: 29290222
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and histologic ocular findings in pompe disease.
    Yanovitch TL; Banugaria SG; Proia AD; Kishnani PS
    J Pediatr Ophthalmol Strabismus; 2010; 47(1):34-40. PubMed ID: 20128552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular and histologic findings in a series of children with infantile pompe disease treated with enzyme replacement therapy.
    Prakalapakorn SG; Proia AD; Yanovitch TL; DeArmey S; Mendelsohn NJ; Aleck KA; Kishnani PS
    J Pediatr Ophthalmol Strabismus; 2014; 51(6):355-62. PubMed ID: 25139343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy.
    Spiridigliozzi GA; Heller JH; Kishnani PS; Van der Ploeg AT; Ebbink BJ; Aarsen FK; van Gelder CM; Van den Hout JM
    Neurology; 2013 Mar; 80(12):1173. PubMed ID: 23509050
    [No Abstract]   [Full Text] [Related]  

  • 11. Unwarranted, long term, alglucosidase alfa enzyme replacement therapy in two non-Pompe disease patients.
    Karam C; Ragole T; Moshe-Lilie O; Chahin N
    Clin Neurol Neurosurg; 2020 Sep; 196():106048. PubMed ID: 32623214
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac response to enzyme replacement therapy in infantile Pompe disease with severe hypertrophic cardiomyopathy.
    Avula S; Nguyen TM; Marble M; Lilje C
    Echocardiography; 2017 Apr; 34(4):621-624. PubMed ID: 28266734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase.
    van Capelle CI; Poelman E; Frohn-Mulder IM; Koopman LP; van den Hout JMP; Régal L; Cools B; Helbing WA; van der Ploeg AT
    Int J Cardiol; 2018 Oct; 269():104-110. PubMed ID: 30049495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy.
    Tanzer F; Buyukkayhan D; Cansu Mutlu E; Kalender Korkmaz F
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1159-62. PubMed ID: 20333876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
    van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
    Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation.
    But WM; Lee SH; Chan AO; Lau GT
    Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oropharyngeal dysphagia in infants and children with infantile Pompe disease.
    Jones HN; Muller CW; Lin M; Banugaria SG; Case LE; Li JS; O'Grady G; Heller JH; Kishnani PS
    Dysphagia; 2010 Dec; 25(4):277-83. PubMed ID: 19763689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of muscle pathology in infantile Pompe disease.
    Schänzer A; Kaiser AK; Mühlfeld C; Kulessa M; Paulus W; von Pein H; Rohrbach M; Viergutz L; Mengel E; Marquardt T; Neubauer B; Acker T; Hahn A
    Neuromuscul Disord; 2017 Feb; 27(2):141-152. PubMed ID: 27927596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.
    Case LE; Bjartmar C; Morgan C; Casey R; Charrow J; Clancy JP; Dasouki M; DeArmey S; Nedd K; Nevins M; Peters H; Phillips D; Spigelman Z; Tifft C; Kishnani PS
    Neuromuscul Disord; 2015 Apr; 25(4):321-32. PubMed ID: 25617983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alglucosidase alfa and Pompe disease: still going strong?
    Lipinski SE
    Mol Genet Metab; 2012 Nov; 107(3):245-6. PubMed ID: 23034445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.